PRO measures | FIL 200 mg + MTX n = 416 | FIL 100 mg + MTX n = 207 | FIL 200 mg n = 210 | MTX n = 416 |
---|---|---|---|---|
HAQ-DI | ||||
 Week 4 | − 0.64 (0.03)*** | − 0.50 (0.04)*** | − 0.56 (0.04)*** | − 0.35 (0.03) |
 Week 12 | − 0.91 (0.03)*** | − 0.82 (0.04)*** | − 0.80 (0.04)*** | − 0.64 (0.03) |
 Week 24 | − 1.00 (0.03)*** | − 0.94 (0.04)** | − 0.91 (0.04)* | − 0.81 (0.03) |
 Week 52 | − 1.03 (0.04)*** | − 0.96 (0.05) | − 0.98 (0.05)* | − 0.87 (0.04) |
SF-36 PCS | ||||
 Week 4 | 7.3 (0.4)*** | 5.8 (0.5)** | 6.4 (0.5)*** | 4.1 (0.4) |
 Week 12 | 11.6 (0.4)*** | 9.6 (0.6)** | 9.4 (0.6)* | 7.9 (0.4) |
 Week 24 | 12.8 (0.5)*** | 11.5 (0.6)* | 10.8 (0.6) | 9.9 (0.5) |
 Week 52 | 13.6 (0.5)*** | 12.0 (0.7) | 12.2 (0.7) | 10.8 (0.5) |
SF-36 MCS | ||||
 Week 4 | 4.6 (0.5)*** | 3.4 (0.6)* | 4.3 (0.6)*** | 1.9 (0.5) |
 Week 12 | 5.7 (0.5)* | 5.7 (0.7) | 5.4 (0.7) | 4.3 (0.5) |
 Week 24 | 5.9 (0.5) | 6.3 (0.7) | 5.5 (0.7) | 5.7 (0.5) |
 Week 52 | 6.5 (0.5) | 6.2 (0.7) | 5.8 (0.7) | 5.8 (0.6) |
FACIT-Fatigue | ||||
 Week 4 | 7.6 (0.5)*** | 6.9 (0.6)*** | 7.1 (0.6)*** | 4.4 (0.5) |
 Week 12 | 10.3 (0.5)*** | 9.3 (0.7) | 9.8 (0.7)* | 8.1 (0.5) |
 Week 24 | 11.3 (0.6) | 11.3 (0.7) | 10.3 (0.7) | 10.0 (0.6) |
 Week 52 | 12.1 (0.6)* | 11.4 (0.8) | 11.6 (0.8) | 10.4 (0.6) |
PtGA | Â | Â | Â | Â |
 Week 4 | − 28 (1.2)*** | − 21 (1.6)** | − 23 (1.6)*** | − 15 (1.2) |
 Week 12 | − 38 (1.3)*** | − 31 (1.7)** | − 32 (1.7)** | − 26 (1.3) |
 Week 24 | − 44 (1.3)*** | − 38 (1.7) | − 38 (1.7) | − 34 (1.3) |
 Week 52 | − 46 (1.4)*** | − 40 (1.8) | − 43 (1.8)** | − 37 (1.4) |
WPAI-RA | ||||
 Absenteeism | ||||
  Week 4 | − 2.9 (2.0) | − 0.3 (2.8) | − 4.8 (2.7) | − 0.2 (2.1) |
  Week 12 | − 6.2 (1.9) | − 8.3 (2.6) | − 2.9 (2.4) | − 3.8 (1.8) |
  Week 24 | − 6.7 (1.7) | − 10.2 (2.3) | − 3.6 (2.1)* | − 9.0 (1.7) |
  Week 52 | − 7.0 (1.8) | − 7.9 (2.5) | − 4.2 (2.4) | − 7.6 (1.9) |
 Presenteeism | ||||
  Week 4 | − 19.4 (2.0)*** | − 22.3 (2.8)*** | − 17.3 (2.6)** | − 7.2 (2.1) |
  Week 12 | − 27.2 (2.0) ** | − 28.2 (2.8)* | − 25.4 (2.6) | − 19.9 (2.0) |
  Week 24 | − 29.8 (1.9) | − 32.2 (2.7) | − 27.5 (2.5) | − 26.8 (2.0) |
  Week 52 | − 33.6 (1.9) | − 30.7 (2.7) | − 32.2 (2.5) | − 30.0 (2.1) |
 Work productivity loss | ||||
  Week 4 | − 19.0 (2.1)*** | − 21.8 (3.0)*** | − 17.1 (2.8)** | − 6.6 (2.2) |
  Week 12 | − 27.6 (2.2)** | − 28.1 (3.1)* | − 23.4 (2.9) | − 19.5 (2.2) |
  Week 24 | − 30.3 (2.1) | − 30.5 (3.0) | − 24.6 (2.8) | − 26.4 (2.2) |
  Week 52 | − 33.4 (2.2) | − 31.2 (3.1) | − 29.8 (2.9) | − 30.3 (2.4) |
 Activity impairment | ||||
  Week 4 | − 23.2 (1.3)*** | − 17.8 (1.7)* | − 19.7 (1.7)** | − 13.5 (1.3) |
  Week 12 | − 32.5 (1.4)*** | − 28.1 (1.8)* | − 30.5 (1.8)*** | − 23.6 (1.4) |
  Week 24 | − 36.4 (1.4)* | − 34.6 (1.8) | − 32.7 (1.8) | − 32.3 (1.4) |
  Week 52 | − 39.9 (1.4)** | − 36.4 (1.9) | − 38.4 (1.9) | − 34.5 (1.5) |